Showing results (621-630 of 895) with videos related to

Sort By:
Pageof 90
Drugs in R&D|March 15, 2014
Stability of etoposide solutions in disposable infusion devices for day hospital cancer practicesAlison Klasen, Romain Kessari, Lionel Mercier, et al.
Drugs in R&D|January 12, 2017
Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion MethodMaryam Bazargan, David J R Foster, Andrew K Davey, et al.
Drugs in R&D|December 22, 2007
Efficacy of a mucoadhesive patch compared with an oral solution for treatment of aphthous stomatitisAvner Shemer, Boaz Amichai, Henri Trau, et al.
Drugs in R&D|April 9, 2017
Psychotropic Drug-Related Fall Incidents in Nursing Home Residents Living in the Eastern Part of The NetherlandsSarah I M Janus, Gezinus H Reinders, Jeannette G van Manen, et al.
Drugs in R&D|January 20, 2017
Drug Exposure and the Risk of Microscopic Colitis: A Critical UpdateAlfredo J Lucendo
Drugs in R&D|March 5, 2017
In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and LimitationsI I Decuyper, E A Mangodt, A L Van Gasse, et al.
Drugs in R&D|May 7, 2014
Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin CPaul K L Chin, Daniel F B Wright, Mei Zhang, et al.
Drugs in R&D|March 29, 2019
Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in NeurodegenerationAlan J Fowler, Michaeline Hebron, Alexander A Missner, et al.
Drugs in R&D|March 1, 2021
Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist AnalysesJoan Mendivil, Mia Malmenäs, Katrin Haeussler, et al.
Drugs in R&D|March 15, 2021
Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule CombinationAnna-Luisa Volk, Aman Mebrahtu, Bong-Kook Ko, et al.
Pageof 90